CECONI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 16.127
EU - Europa 4.405
AS - Asia 2.048
SA - Sud America 17
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 1
Totale 22.616
Nazione #
US - Stati Uniti d'America 16.117
IT - Italia 1.619
CN - Cina 1.396
UA - Ucraina 1.222
TR - Turchia 563
DE - Germania 525
GB - Regno Unito 427
FI - Finlandia 258
SE - Svezia 174
FR - Francia 67
PL - Polonia 31
VN - Vietnam 15
ES - Italia 13
AU - Australia 11
IN - India 11
RU - Federazione Russa 11
BE - Belgio 9
GE - Georgia 8
HK - Hong Kong 8
KR - Corea 8
NL - Olanda 8
BR - Brasile 7
CH - Svizzera 6
ID - Indonesia 6
IR - Iran 6
JP - Giappone 6
TW - Taiwan 6
AL - Albania 5
CA - Canada 5
EU - Europa 5
IE - Irlanda 5
MX - Messico 5
CL - Cile 4
CO - Colombia 4
PT - Portogallo 4
RO - Romania 4
AM - Armenia 2
AT - Austria 2
BG - Bulgaria 2
GR - Grecia 2
HR - Croazia 2
LT - Lituania 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SG - Singapore 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
IL - Israele 1
MD - Moldavia 1
MM - Myanmar 1
PE - Perù 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 22.616
Città #
Woodbridge 2.374
Fairfield 2.367
Houston 1.349
Jacksonville 1.347
Ashburn 1.039
Seattle 985
Chandler 887
Ann Arbor 886
Wilmington 799
Cambridge 795
Izmir 432
Nanjing 410
Princeton 349
San Diego 232
Boardman 186
Beijing 146
Shenyang 135
Nanchang 119
Milan 110
Hebei 81
New York 79
Rome 79
San Mateo 76
Changsha 70
Falls Church 68
Jiaxing 66
Ferrara 62
Tianjin 58
Jinan 57
Mountain View 47
Verona 42
Ningbo 39
Zhengzhou 39
Bremen 38
Redwood City 37
London 36
Shanghai 36
Taizhou 36
Naples 32
Philadelphia 30
Warsaw 30
Norwalk 27
Addison 25
Tappahannock 25
Napoli 24
Indiana 22
Kunming 20
Des Moines 18
Orange 18
Bari 17
Chicago 17
Washington 17
Hangzhou 16
Bologna 15
Dearborn 14
Dong Ket 14
Genova 14
Guangzhou 14
Turin 14
Helsinki 13
Los Angeles 13
Florence 12
Changchun 11
Kilburn 11
Padova 11
Palermo 11
Redmond 11
Cagliari 9
Torino 9
Brescia 8
Brussels 8
Catania 8
Tbilisi 8
Yellow Springs 8
Auburn Hills 7
Haikou 7
Lanzhou 7
Hounslow 6
Hualien City 6
Modena 6
Caserta 5
Como 5
Fuzhou 5
Livorno 5
Monmouth Junction 5
Pozzo Di Gotto 5
Sheffield 5
Siena 5
Taranto 5
Trieste 5
Bacoli 4
Chiswick 4
Frankfurt am Main 4
Genoa 4
Giugliano in Campania 4
Granada 4
Leawood 4
Melbourne 4
Nogarole Rocca 4
Omegna 4
Totale 16.696
Nome #
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.628
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 158
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion. 153
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 145
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 142
Enhanced expression and activity of xanthine oxidoreductase in the failing heart. 137
Uric acid and coronary artery disease: An elusive link deserving further attention 132
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 129
Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium. 128
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) 122
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). 122
A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines 116
Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients. 113
Third Universal Definition of Myocardial Infarction 113
Guidelines on myocardial revascularization 111
Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using doppler measures of myocardial strain. 111
Postinfarction Left Ventricular Free Wall Rupture: Original Management and Surgical Technique 110
Is stunning an important component of preconditioning? 110
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 110
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association. 109
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression 109
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 109
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy 109
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 109
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 109
Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability. 108
Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice 108
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation 108
Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? 107
Occurrence of oxidative stress during reperfusion of the human heart. 107
Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling. 107
Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 107
In vitro administration of ergothioneine failed to protect isolated ischaemic and reperfused rabbit heart 107
Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts 106
null 106
Specific properties and effect of perindopril in controlling the renin-angiotensin system. 106
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 106
Relevance of apoptosis in influencing recovery of hibernating myocardium 106
null 106
Right heart failure chronically stimulates heat shock protein 72 in heart and liver but not in other tissues. 106
Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes 106
Incremental exercise using progressive versus constant pedaling rates: A study in cardlac patients 105
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: Study protocol for a randomized controlled trial 105
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE 105
Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies 104
Plasma levels of atrial natriuretic factor and urinary excretion of arginine vasopressin and catecholamines in children with congenital heart disease effect of cardiac surgery 103
Revascularization of hibernating myocardium: rate of metabolic and functional recovery and occurrence of oxidative stress. 103
Oxygen Free Radicals in Shock 103
Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. 102
Effect of superoxide generation on rat heart mitochondrial pyruvate utilization 102
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 102
Selective and specific I f inhibition with ivabradine: New perspectives for the treatment of cardiovascular disease 102
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 102
Traditional and new composite endpoints in heart failure clinical trials: Facilitating comprehensive efficacy assessments and improving trial efficiency 102
Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: Experimental studies 101
Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure. 101
The ACE-inhibitor Perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE 101
New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage 100
Different outcomes of the reperfused myocardium: insights into the comments of stunning and hibernation. 100
Oxygen free radicals and reperfusion injury; the effect of ischaemia and reperfusion on the cellular ability to neutralise oxygen toxicity 100
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). 100
Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation. 99
Anti-ischaemic effect of ivabradine 99
Chromogranin A in heart failure - A novel neurohumoral factor and a predictor for mortality 99
Third universal definition of myocardial infarction 99
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 99
Evidence against malondialdehyde bound to cellular constituents in phospholipid peroxidation 99
Anti-ischemic effect of IVA in isolated rabbit hearts: Modulation of cardiac metabolism 99
Left ventricular dysfunction due to stunning and hibernation in patients. 98
Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition 98
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review 98
Role of A2A receptor in the modulation of myocardial reperfusion damage. 98
Myocardial damage during ischaemia and reperfusion. 97
One heart, two lungs together forever 97
Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina 97
Effects of felodipine on the ischemic heart: insight into the mechanism of cytoprotection. 96
Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage. 96
Metabolic changes during post-ischaemic reperfusion. 96
Mechanical vs. electrical dyssynchrony for CRTselection in patients with HF 96
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). 96
Effect of L-carnitine derivatives on heart mitochondrial damage induced by lipid peroxidation. 96
The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. 96
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 96
Cardioprotection by nisoldipine: role of timing of administration. 95
Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure. 95
Oxidative stress during myocardial ischaemia and heart failure. 95
Protective effect of a prostacyclin-mimetic on the ischaemic-reperfused rabbit myocardium. 95
The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria. 95
null 95
Differential action of ACE inhibitors on the eNOS pathway 95
Preventive cardiology: comparisons of European and Italian projects with the Cardiac Units from Emilia Romagna region. A workshop of IACPR/GICR - Emilia Romagna 95
Third Universal Definition of Myocardial Infarction 95
Activation of the neuroendocrine response in heart failure: adaptive or maladaptive process? 95
Specific and selective I-f inhibition: expected clinical benefits from pure heart rate reduction in coronary patients 95
Lipid peroxidation in normal pregnancy and preeclampsia 94
The occurrence of oxidative stress during reperfusion in experimental animals and men. 94
The ACE-inhibitor perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE 94
Effect of ivabradine on structural and electrophysiological remodelling in a rat model of heart failure 94
Future strategies of reverse remodeling prevention of hibernation 94
null 94
Totale 12.047
Categoria #
all - tutte 74.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.673
Totale 77.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.811 0 0 0 0 0 0 0 0 0 607 820 1.384
2019/20205.399 881 186 185 803 419 606 454 585 418 577 165 120
2020/20213.361 295 343 198 452 178 362 78 437 76 438 353 151
2021/20222.999 85 374 306 82 107 137 167 151 100 187 262 1.041
2022/20232.315 277 29 78 259 391 382 52 243 315 24 152 113
2023/2024813 178 166 77 50 66 130 48 31 18 49 0 0
Totale 22.862